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a b s t r a c t
The VZV genome has two origins of DNA replication (oriS), each of which consists of an AT-rich sequence
and three origin binding protein (OBP) sites called Box A, C and B. In these experiments, the mutation in
the core sequence CGC of the Box A and C not only inhibited DNA replication but also inhibited both
ORF62 and ORF63 expression in reporter gene assays. In contrast the Box B mutation did not inﬂuence
DNA replication or ﬂanking gene transcription. These results suggest that efﬁcient DNA replication
enhances ORF62 and ORF63 transcription. Recombinant viruses carrying these mutations in both sites
and one with a deletion of the whole oriS were constructed. Surprisingly, the recombinant virus lacking
both copies of oriS retained the capacity to replicate in melanoma and HELF cells suggesting that VZV
has another origin of DNA replication.
& 2015 Elsevier Inc. All rights reserved.
Introduction
Varicella-zoster virus (VZV), a neurotropic herpesvirus, causes
two diseases, varicella (chickenpox) during primary infection and
herpes zoster (shingles) upon reactivation from latency in sensory
ganglia. The VZV genome consists of a 125 kb linear double-
stranded DNA molecule that encodes at least 71 genes (Straus
et al., 1982). The linear sequence of VZV genes is similar to that of
herpes simplex virus type 1 (HSV-1) and includes the coding
sequences for orthologues of the seven HSV-1 proteins required
for origin-dependent DNA replication (Arvin and Gilden, 2013).
By analogy to HSV, two origins of DNA replication (oriS) within
the internal repeats (IRs) and terminal repeats (TRs) bounding the
US segment are identiﬁed within the VZV genome. These two
copies of oriS are located in the intergenic region between the two
immediate early genes encoding IE62 and IE63 proteins. HSV has
another origin of DNA replication oriL near the center of the HSV-1
UL region (Davison and Scott, 1985, 1986; Stow, 1982; Stow and
McMonagle, 1983; Stow and Davison, 1986). HSV-1 oriL has been
shown to be dispensable for replication of HSV DNA (Balliet et al.,
2005;Weller et al., 1985) but has been implicated in HSV pathogenesis
and reactivation from latency (Balliet and Schaffer, 2006). The equiva-
lent region in the VZV genome is comprised of a bidirectional
promoter that regulates the transcription of the VZV DNA polymerase
catalytic subunit (ORF28) and DNA binding protein (ORF29) genes and
does not contain any origin of DNA replication (Meier and Straus,
1993; Stow and Davison, 1986; Yang et al., 2004).
VZV oriS contains a 46-bp AT-rich palindrome and three
consensus binding sites for the VZV origin-binding protein (OBP)
(ORF51). All three OBP-binding sites (Boxes A, B, and C) for VZV
[50-C(G/A)TTCGCACT-30] are upstream of the palindrome (Fig. 1).
This is in contrast to the structure of HSV oriS, where the OBP-
binding sites (Boxes I, II, and III) are located both upstream and
downstream of the AT-rich element (Hay and Ruyechan, 2007;
Stow and Davison, 1986). Using the in vitro DpnI assay, Stow et al.
(1990) showed previously that the A site is absolutely required for
DNA replication and that the deletion of the C site results in a
decreased level of replication in VZV. In contrast, the deletion of
the B site showed no effect on the extent of replication. In contrast,
all three OBP-binding sites in HSV are required for efﬁcient DNA
replication (Stow and McMonagle, 1983; Balliet and Schaffer,
2006; Deb and Doelberg, 1988; Hernandez et al., 1991; Martin
et al., 1991; Olsson et al., 2009; Weir and Stow, 1990).
Stow et al. (1990) also showed that the CGC motif within the 10
nucleotides forming Box A, C and B is crucial for the binding of
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ORF51 to these sites. Previous studies showed that either the
complete deletion of the 10 nucleotides of Box A or the CGC
mutations to AAA inhibits the VZV origin dependent DNA replica-
tion using the DpnI replication assay (Stow et al., 1990; Khalil et al.,
2008, 2011, 2012). The deletion of the 10 nucleotides of Box C
inhibited VZV origin dependent DNA replication 50–80% while the
deletion of Box B has insigniﬁcant effect on VZV DNA replication
(Stow et al., 1990). In this study we expand our understanding of
the role of Box A, C and B by investigating the inﬂuence of the CGC
motif mutation in these three origin binding protein boxes on VZV
origin dependent DNA replication and the ﬂanking gene
transcription.
Our results suggest the presence of another functional origin of
DNA replication within the VZV genome. This origin(s) might be
analogous to the HSV oriL.
Results
Origin binding protein Boxes A, C and B inﬂuence origin-dependent
DNA replication
The ﬁrst set of experiments employed the pLitmus R62/63 F
plasmid which contains the whole intergenic region (1.5 kb)
between ORF62 and ORF63 genes and includes the complete VZV
oriS structure. The assays were performed as described previously,
by transfection of plasmids containing the wild type or mutant
oriS sequence followed by VZV superinfection (Khalil et al., 2008,
2011, 2012).
DpnI replication assays using the wild type pLitmus R62/63 F
plasmid showed a detectable signal at the position predicted for
the replicated DNA (Fig. 2A and B). In contrast, assays performed
under the same conditions using the Box A mutant plasmid
resulted in loss of the replicated DNA. This conﬁrmed the results
of Stow et al. (1990) who showed that Box A is required for
VZV origin-dependent DNA replication. The CGC motif mutation of
Box C inhibited oriS-dependent DNA replication by about 80%
which was a statistically signiﬁcant inhibition. On the other hand,
the CGC motif substitution to AAA of Box B had no effect on the
VZV DNA, as shown in Fig. 2A and B. The effect of CGC motif
mutation of Box C and B on oriS-dependent DNA replication is in
agreement with the effect of the deletion of both boxes shown by
Stow et al. (1990).
Inﬂuence of Box A, C and B on the expression of ORF62 and ORF63
genes
To determine the involvement of the origin binding protein
Boxes A, C and B in the expression of the ﬂanking genes ORF62 and
ORF63, we carried out a series of luciferase reporter gene assays
examining this effect in the presence and absence of the VZV DNA
polymerase inhibitor phosphonacetic acid (PAA). DpnI replication
assays conﬁrmed that the presence of 400 μg/ml of PAA comple-
tely inhibited oriS-dependent DNA replication (data not shown).
The results of the luciferase reporter assays are shown in
Fig. 2C and D.
The Box A mutation inhibited the expression of ORF62 and
ORF63 genes by about 7 and 5-fold, respectively, compared to the
wild type level, in the absence of PAA. The Box C mutation
inhibited the expression of both ORF62 and ORF63 by about 2-
fold in the absence of PAA. In contrast, the Box B mutation did not
have a signiﬁcant effect on either ORF62 or ORF63 expression in
the absence of PAA. The presence of PAA inhibited the expression
of ORF62 and ORF63 genes by about 7 and 5-fold respectively in
the experiments using the wild type pLitmus R62/63 F plasmid
(Fig. 2C and D). Mutations in any of the origin binding protein
Boxes A, C or B had no statistically signiﬁcant effect on the
expression of ORF62 and ORF63 genes compared to the wild type
level in the presence of PAA. These results suggest that the effects
of the Box A and C mutations on the expression of ORF62 and
ORF63 reporter genes are due to their role in oriS-dependent DNA
replication, and not because they are part of the promoters of
these genes.
Fig. 1. The structure of the HSV-1 and VZV (A) genome and (B) oriS origins of DNA replication. (A) IRs and TRs are the internal and terminal repeat regions that bound the
unique short segment of the genome. IRL and TRL are the internal and terminal repeat regions that bound the unique long segment of the genome. Two oriS copies are
present in the IRs and TRs of the unique short segment in both HSV-1 and VZV. The HSV-1 oriL is present in the intergenic region between UL28 and UL29. (B) The positions
of OBP binding site boxes and their orientations in HSV and VZV genomes. (C) A schematic diagram shows the structure of the wild type pLitmus R62/63 F plasmid used in
the experiments where Renilla and ﬁreﬂy luciferase genes were placed in the position of ORF62 and ORF63 respectively.
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Inﬂuence of the complete deletion of oriS, and origin binding protein
box mutations, on VZV growth kinetics in melanoma and HELF cells
Since some of the OBP box mutations affected DNA replication
and ﬂanking gene transcription, their contribution to VZV replica-
tion was now investigated using mutant viruses. Three mutant
viruses, one with the CGC motif mutation in Box C, one with the
CGC motif mutation in Box B and the last one with a complete oriS
structure deletion (deleting the region between nucleotide
110103–110319 and 119784–120000) were constructed. Transfec-
tions including a cosmid containing the CGC motif mutation in Box
A did not yield a recombinant virus with this mutation. The
growth kinetics of the wild type pOka recombinant virus and the
three mutant recombinant viruses were evaluated in melanoma
and HELF cells as shown in Fig. 3A and B respectively.
In melanoma cells, there was a slight but statistically signiﬁcant
delay in the growth of both Box C andΔoriS mutant viruses at day
1 post-infection. At day 2, only the Box C mutant virus displayed a
signiﬁcantly slower growth kinetics compared to pOka. The ΔoriS
mutant grew as well as the wild type virus at day 2 post-infection.
Titers of the Box C and ΔoriS mutant viruses did not differ from
pOka from days 3 to 5 post-infection. The titers of the Box B
mutant virus were similar to pOka over the 5 days interval
(Fig. 3A).
In contrast, the three mutant viruses showed impaired growth
compared to pOka at day 1 post-infection in HELF cells which was
statistically signiﬁcant. Only the Box C mutant virus had statisti-
cally signiﬁcant inhibition in growth kinetics compared to pOka at
day 2 post-infection. Titers were equivalent for the three mutants
and pOka at days 3 and 4 post-infection. The Box B mutant titers
were lower than pOka at day 5, while the Box C mutant and ΔoriS
mutant viruses were equal to pOka titers at day 5 (Fig. 3B).
IE62 and IE63 expression and VZV genome copies in mutant and pOka
infected cells
Next, we tested IE62 and IE63 expression levels in melanoma
cells using the same mutant viruses and pOka at 36 h post-
infection. IE62 and IE63 expression levels were decreased by 2–3
fold in cells infected with the Box C mutant and ΔoriS mutant
viruses. In contrast, no signiﬁcant change in IE62 and IE63
expression levels was detected in melanoma cells infected with
the Box B mutant virus compared to pOka (Fig. 3C).
VZV genome copies per nanogram of human DNA for the wild
type and mutant viruses in melanoma cells were quantiﬁed by
quantitative PCR. VZV genome copies did not change signiﬁcantly
for any of the three mutant viruses compared to pOka at 36 h post-
infection (Fig. 3D).
Discussion
Davison and Scott (1985) proposed the presence of a sequence
that may be a part of the VZV replication origin within the TRs and
IRs repeat regions based on the presence of an AT-rich sequence in
a position equivalent to that of HSV oriS. Stow and Davison (1986)
subsequently identiﬁed the presence of two VZV oriS copies
within this repeat region, but when they tested the KpnI e
fragment of the VZV genome, which contains the equivalent
sequence of HSV oriL, they did not detect the presence of any
Fig. 2. The effect of Box A, Box C and Box B mutations on origin-dependent DNA replication and ﬂanking gene expression in the context of VZV-MSP superinfection.
(A) A typical Southern blot analysis of the effects on DNA replication of CGC motif mutation in Box A, C and B to AAA. The upper band (R) indicates the position of DpnI
resistant DNA resulting from replication in MeWo cells. The lower band (U) indicates the position of unreplicated input plasmid. (B) A histogram summarizing the data from
three independent DpnI replication assays analyzed at 48 h post-VZV-MSP superinfection. (C) Results of triplicate assays comparing the effect of the presence of Box A, Box C
and Box B mutations on the expression levels of the Renilla luciferase reporter gene present at the position of ORF62 and (D) the ﬁreﬂy luciferase reporter gene present at the
position of ORF63. The promoter activities in the presence of VZV-MSP superinfection are represented as RLU/β-Gal units. The black and gray bars represent experiments
done in the absence and presence of 400 μg/ml of PAA respectively. Statistical signiﬁcance was determined by a one-way ANOVA analysis of variance followed by Tukey's
post-hoc test.
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equivalent VZV oriL within this sequence. It is possible however,
that rearrangement of any origin sequence in the KpnI e fragment
of VZV took place during the replication of the plasmid in bacteria,
as been seen with HSV oriL. Since this work, no further analysis
has been done to search for the presence of additional origin(s) of
DNA replication in any other segment of the VZV genome.
Here we determined the involvement of the VZV origin binding
protein boxes in modulating the expression of ﬂanking genes, as
well as oriS-dependent DNA replication and VZV growth in vitro.
Mutations were introduced in the CGC motif within Box A, C and B
sequences in a plasmid that contains the complete intergenic
region between ORF62 and ORF63 genes, since this CGC motif was
found to be essential for the binding of the origin binding protein
ORF51 to these sites (Stow et al., 1990; Chen and Olivo, 1994). Our
results conﬁrmed the previous ﬁndings of Stow et al. (1990), done
by deleting the 10 nucleotides forming Box A, C and B, that Box A is
essential for the oriS-dependent DNA replication and Box C is an
enhancer, while Box B is dispensable for any role. We found roles
for the three origin binding protein boxes in ORF62 and ORF63
expression equivalent to their roles in oriS-dependent DNA repli-
cation. Boxes A and C were found to enhance ﬂanking gene
transcription in the experiments done in the absence of PAA while
there was no effect in the presence of PAA. In contrast there was
no inﬂuence of the Box B mutation on either IE62 or IE63
expression in the presence or absence of PAA. These results
suggest that the involvement of Box A and C in ﬂanking gene
transcription depends on their role in oriS-dependent DNA repli-
cation. It might also suggest that origin-dependent DNA replica-
tion and ﬂanking gene transcription are coupled in VZV, which is
not the case in HSV (Nguyen-Huynh and Schaffer, 1998; Summers
and Leib, 2002).
The data gathered on the inﬂuence of origin binding protein
Boxes A, C and B on VZV origin-dependent DNA replication and
ﬂanking gene transcription led us to the following model. At the
immediate early phase of the lytic infection, IE62 is expressed.
Then at the early phase, IE62 activates expression of early genes,
including the seven VZV replication factors (ORF6, 16, 28, 29, 51, 52
and 55). These factors allow origin-dependent DNA replication to
start. This DNA replication further enhances ORF62 and ORF63
expression during early and late stages of infection. Thus, we
observed that the presence of PAA or Box A and/or C mutations
inhibit the expression of ORF62 and ORF63. This may also explain
why late gene expression is linked to VZV DNA replication and
why the inhibition of VZV DNA replication using PAA inhibits late
virus gene expression. That inhibition of origin-dependent DNA
replication inhibits the expression of ORF62 is clearly shown in
Fig. 2; this likely decreases the amount of IE62 available inside the
infected cells. This, in turn, might be the cause of the inhibition of
expression of late genes, as they represent about 80% of the total
VZV genes.
Fig. 3. The effect of ΔoriS, Box C and Box B mutations on VZV replication in melanoma and HELF cells, and IE62 and IE63 expression levels in melanoma cells. Growth
kinetics of the pOka wild type and mutant viruses are shown in (A) melanoma cells and (B) HELF cells. Cells were inoculated at 103 PFU/ml with wild type and mutant viruses
and infectious virus yields were determined for 5 days after inoculation. (C) Western blot analyses show the expression levels of IE62, IE63 and α-tubulin. α-tubulin was used
as a loading control in the experiments. The blots were scanned by densitometry to obtain quantitative data (in triplicate). (D) A histogram showing the VZV genome copies/
ng of human DNA at 0 and 36 h post-infection of melanoma cells using pOka and mutant viruses. Statistical signiﬁcance was determined by a one-way ANOVA analysis of
variance followed by Tukey's post-hoc test.
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The ability of ΔoriS virus to grow in melanoma and HELF cells
and the lack of a signiﬁcant inﬂuence of this deletion on the VZV
genome copies in melanoma cells suggest the presence of one or
more origin(s) of DNA replication within the VZV genome outside
of the intergenic region between ORF62 and ORF63 genes. This
would be analogous to the ability of HSV to replicate in the
absence of the two oriS origins (Igarashi et al., 1993). Taking this
ﬁnding together with the observation that a Box A mutation was
not compatible with VZV replication in melanoma cells, we can
conclude that this origin requires the origin binding protein ORF51
and an alternative origin binding protein box in order to be
functional. The fact that the Box A mutation was lethal for
replication might be attributed to the absence of any other
identical OBP box in the genome except for the three present in
each copy of the VZV oriS. In addition, the presence of wild type
Box C and B sequences in the Box A mutant virus may act as
competitors for binding of ORF51 to any other partial OBP site in
any alternative origin of DNA replication. Stow et al. (1990) and
Chen and Olivo (1994) showed that ORF51 binds to the wild type
Boxes A, C and B with high afﬁnity and more than to any mutant
sequence.
Analysis of the whole genome (125 kb) of VZV pOka indicates
that it does not have any other copy of an origin binding protein
box identical to the VZV oriS structure. However, we have found
one partial OBP site with 90% identity to Boxes B and C, between
nucleotides 43424 and 43432. In addition, there are 51 partial OBP
sites in VZV with 80% identity to either Box A or (B and C), as
shown in Fig. 4. We did not go beyond 80% because the partial OBP
site in the downstream region of VZV oriS, which we called Box D,
is 70% identical to Box A, and was shown by Stow et al. (1990) and
Chen and Olivo (1994), to be incapable of binding ORF51.
Another important factor in the minimum VZV origin of DNA
replication is the presence of an AT-rich stretch. Stow and Davison
(1986) showed that deletion of 20 nucleotides in the AT-rich
stretch of oriS in VZV Dumas did not eliminate the ability to
replicate. This ﬁnding may suggest that the presence of a short AT-
rich stretch proximal to a partial OBP site can act as a nucleus for
forming an alternative VZV origin of replication, compensating for
the absence of the two oriS copies in the mutant virus. Sequence
analysis of the VZV genome showed the presence of 38 short
AT-rich stretches, ranging from 7 to 10 nucleotides, outside of the
two VZV oriS structures as shown in Fig. 4.
The last important point is the distance between a partial OBP
site and an AT-rich stretch. Box A is 7 nucleotides from the AT-rich
stretch and Box C is 68 nucleotides from the AT-rich stretch. Box C
and B are not able to compensate for the absence of a functional
Box A (due either to point mutations in the CGC motif or to
deletion of the entire region), although the distance between Box
C and AT-rich sequence is only 68 nucleotides. In our analysis of
the VZV genome, all partial OBP sites are distant from the nearest
short AT-rich sequence by at least 100 nucleotides except for one.
That is located between nucleotides 69184 and 69193, in the
coding sequence of ORF38, and is upstream from the nearest short
AT-rich sequence by 18 nucleotides, similar to the three OBP sites
in the two copies of VZV oriS. This sequence might be an
alternative origin of DNA replication that compensates for the
absence of the two copies of oriS in our studies.
Another possibility that Stow and Davison (1986) have dis-
cussed, is the presence of a non-canonical origin(s) that is different
from the VZV or HSV oriS and perhaps similar to EBV oriP (Yates
et al., 1984). The EBV oriP does not contain either an AT-rich region
or OBP sequences similar to that of HSV and VZV.
This is the ﬁrst report that indicates the possibility of the
presence of another origin of DNA replication within the VZV
genome. Future studies will involve further analysis of the VZV
genome to seek to identify and characterize potential new origins
of replication. The relevance of the likely additional origin of DNA
replication to VZV infection in vivo remains unknown.
Conclusion
The effect of the origin binding protein Boxes A, C and B
mutation on origin-dependent DNA replication and transcription
of the ﬂanking genes in VZV suggests a possible coupling between
DNA replication and gene transcription in VZV. In contrast, neither
the oriS nor oriL of HSV have any inﬂuence over the transcription
of ﬂanking genes.
That the ΔoriS virus is able to grow in melanoma and HELF
cells suggests the presence of one or more origins of DNA
replication outside of the region between ORF62 and ORF63 genes
in VZV. This is the ﬁrst report that indicates the possible presence
of other origins of DNA replication in VZV.
Fig. 4. Schematic of the VZV genome indicating the distribution of short AT-rich sequences (7–10 nucleotides length) and partial OBP sites (80–90% identity). The sequence
of the 80% partial OBP site that is in proximity to a short AT-rich stretch appears under the schematic. The partial OBP site is in bold italics and the short AT-rich stretch is in
bold underlined.
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Materials and methods
Cells and viruses
MeWo cells, a human melanoma cell line, and primary human
embryonic lung ﬁbroblasts (HELF), were grown in Eagle's minimal
essential medium supplemented with 10% fetal bovine serum
(Spengler et al., 2000). VZV strains MSP and pOka were propagated
in MeWo cell and HELF cell monolayers as previously described
(Lynch et al., 2002; Peng et al., 2003).
Immunoblot analysis
Whole cell lysates of VZV infected MeWo cells were prepared in
lysis buffer (50 mM Tris–HCl, pH 7.5, 0.15 M NaCl, 1 mM EDTA, 0.1%
Triton X-100 and protease inhibitor cocktail (Roche, Mannheim,
GE, added per the manufacturer's instructions)) and analyzed for
IE62 and IE63 expression by immunoblot as previously described
(Yang et al., 2004) using rabbit antisera against full-length IE62
(Spengler et al., 2000) and IE63 (Zuranski et al., 2005). Mouse
monoclonal antibody against α-tubulin was obtained from Sigma-
Aldrich (St. Louis, MO). Quantiﬁcation of the relative amounts of
IE62, IE63 and α-tubulin was done using a BioRad GS700 Imaging
Densitometer (BioRad Hercules, CA). Statistical signiﬁcance was
determined by one-way ANOVA analysis of variance followed by
Tukey's post-hoc test.
Plasmids
The plasmid pLitmus R62/63 F contains the complete 1.5 kb
intergenic region of VZV DNA between ORF62 and ORF63 genes of
strain pOka, including the VZV oriS structure, inserted between
genes encoding Renilla and ﬁreﬂy luciferases (Promega), respec-
tively, so that the luciferase genes acted as reporters of ORF62 and
ORF63 transcription (Fig. 1C) (Jones et al., 2006).
Plasmids containing Box A, C and B site-speciﬁc mutations within
the oriS region were generated by mutating wild-type pLitmus R62/
63 F plasmids using the QuikChange site-directed mutagenesis
kit (Stratagene, La Jolla, CA) and the following primer sets: 50-
GGCATGTGTCCAACCACCGTTAAAACTTTCTTTCTATA TATATAT-30 and
50-ATATATATATAGAAAGAAAGTTTTAACGGTGGTTGGACACA TGCC-30
for the Box A mutation; and the following primer sets: 50-
TACACTCTTTTA ATCTGCATTAAAACTTCCCGTTTTTTCACTGTA-30 and
50-TACAGTGAAAAAACG GGAAGTTTTAATGC AGATTAAAAGAGTGTA-
30 for the Box C mutation; and the following primer sets: 50-TC
TGAGGCATGTAAACCCATTAAAACTTCCTGGGGTG GAATGGGG-30 and
50-CCCCATTCCACCCCAGGAAGTTTTAATGGGTTTACATGC CTCAGA-30
for the Box B mutation. The mutated nucleotides are indicated in
bold. All primers were synthesized by Integrated DNA Technologies
(Coralville, IA). The mutations were veriﬁed by sequencing at the
Roswell Park Cancer Institute sequencing facility, Buffalo NY.
DpnI replication assays
MeWo cells were transfected with Lipofectamine reagent
(Invitrogen, Carlsbad, CA) according to the manufacturer's instruc-
tions. 4 μl of Lipofectamine reagent was used per μg of transfected
DNA in each transfection. Transfections were performed in 100-
mm-diameter dishes, with 2.1106 MeWo cells per dish seeded in
12 ml of complete growth medium. The medium was replaced
three hours before transfection and cells were 80% conﬂuent at the
time of transfection. Origin-dependent DNA replication experi-
ments were performed as described previously (Khalil et al.,
2008). The cells were transfected with 5 μg of wild-type or mutant
pLitmus R62/63 F plasmids. At 6 h posttransfection, cells were
superinfected with VZV strain MSP (Grose et al., 2004) by adding
0.4 infected cells per 1 uninfected cell to each monolayer. Total
cellular DNA was prepared at 48 h after superinfection, and the
DNA was isolated by phenol–chloroform extraction followed by
ethanol precipitation. The DNA was digested with DpnI and EcoRI
(Stow and Davison, 1986), and analyzed by Southern blot hybridi-
zation. The blots were probed with a 476-bp PCR product prepared
from pLitmus R62/63 F by using primers 50-TAGGCCACCACTTCAA-
GAACTCTGT-30 and 50-AGCAAAAGGCCAGCAAAAGG CCAGG-30; the
probe was end labeled with [α-32 P] ATP by using T4 kinase
(Invitrogen, Carlsbad, CA).
The resulting bands were quantiﬁed by PhosphorImager (Mole-
cular Dynamics, Sunnyvale, CA) analysis. The ratio of replicated
plasmid to input plasmid represents the replication efﬁciency of
the test plasmid. The data from representative experiments are
presented as the means of data from triplicate DpnI replication
assays. Statistical signiﬁcance was determined by a one-way
ANOVA followed by Tukey's post-hoc test.
Reporter gene assays
Luciferase reporter gene assay experiments were performed in
MeWo cells as previously described (Yang et al., 2004). Transfec-
tions were performed using 12-well plates with 2105 MeWo
cells seeded in each well 24 h before transfection. Cells were
transfected with 1 μg of each reporter vector (pLitmus R62/63 F)
using Lipofectamine reagent (Invitrogen, Carlsbad, CA), along with
0.4 μg of β-galactosidase (β-Gal)-expressing plasmid (Invitrogen,
Carlsbad, CA) as a control of transfection efﬁciency. The cells were
super infected with VZV MSP 24 h post-transfection using
0.4 infected cells per 1 uninfected cell.
The cells were lysed 48 h post-transfection or super-infection
in 250 μl of lysis buffer (50 mM HEPES, pH 7.4, 250 mM NaCl, 1%
NP-40, 1 mM EDTA). Control experiments without VZV infection
were done for each plasmid to determine basal expression levels.
Dual-luciferase assays were performed using dual-luciferase reporter
kit (Promega) according to themanufacturer's instruction. Transfection
experiments were repeated a minimum of three times.
Generation and growth kinetics of pOka recombinant viruses with
mutations in the oriS structure
Recombinant viruses were generated using cosmids derived
from parental Oka (Niizuma et al., 2003). The entire pOka genome
is included in four overlapping cosmids, designated Fsp73 (pOka
nucleotides [nt] 1–33128), Spe14 (pOka nt 21795–61868), Pme2
(pOka nt 53755–96035), and Spe23 (pOka nt 94055–125124). The
oriS is located in the internal repeat sequence/terminal repeat
sequence (IRs/TRs) regions in cosmid Spe23. Four primers were
designed to amplify a 4.5 kb fragment in two PCR products and
to ligate the fragments together with the pLitmus(ORF59-65) in a
three PCR product ligation reaction. The primer sequences to
amplify these PCR products for Box B mutant viruses are as
follows: for the ﬁrst PCR product which contains CGC motif
mutation in Box B, 50-CCAGGA AGTTTTAATGGGTTTACATGCCT-
CAG-30 and 50-ACAGTAGATCAGGTTAATCAG CGCGCGGTACTGTC-30,
and for the second PCR product 50-GGTGGAATGGGG
TGGGGTGGGGGGGTG -30 and 50-CGCGGATGCATTTATTATCGGGC-
GACAAT CC-30. The primer sequences to amplify these PCR
products for Box C mutant viruses are as follows: for the ﬁrst
PCR product which contains CGC motif mutation in Box C, 50-
ACGGGAAGTTTTAATGCAGATTAAAAGAGTGTATC-30 and 50-ACA
GTAGATCAGGTTAATCAGCGCGCGGTACTGTC-30, and for the second
PCR product 50-TTTTTCACTGTATGGGTTTTCATGTTTTGGCATG-30
and 50-CGCGG ATGCATTTATTATCGGGCGACAATCC-30. The primer
sequences to amplify these PCR products for ΔoriS mutant viruses
are as follows: for the ﬁrst PCR product, 50-GAGAGAGAGA-
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GAGAGAGAGAGGGAGAGAGTTTC-30 and 50-CGCGGATGCATT TAT-
TATCGGGCGACAATCC-30, and for the second PCR product 50-
GGTTTACAT GCCTCAGATATGAAGTTCTTCGAC-30 and 50-ACAGTA-
GATCAGGTTAATCAGC GCGCGGTACTGTC-30. The ﬁrst PCR product
was digested with EcoRV and the second PCR product was
digested with AatII. The digested PCR products were cloned into
EcoRV/AatII, digested pLitmus(ORF59-65) and the SphI fragment
was transferred from pLitmus(ORF59-65) to pLitmus(ORF66-71).
Box C and B mutations and ΔoriS deletion were ﬁrst introduced
into pLitmus(ORF59-65) and pLitmus(ORF66-71) and were seq-
uenced to verify the mutations. To insert these mutations into the
pSpe23 cosmid, an NheI/AvrII fragment was excised from the
pLitmus(ORF59-65) plasmid and ligated into pSpe23. In the ﬁnal
step, to insert the mutation into the other copy of the origin, an
AscI/AvrII fragment from plasmid pLitmus(ORF66-71) was ligated
into the corresponding mutant pSpe23 cosmid.
Recombinant viruses were isolated by the transfection of
melanoma cells with the wild type or the mutated Spe23 cosmid
and the other three intact cosmids, Fsp73, Spe14, and Pme2. To
conﬁrm the targeted mutations in the oriS sequence, genomic DNA
was extracted from virus-infected melanoma cells with DNAzol
reagent (Invitrogen, Carlsbad, CA). A PCR fragment covering the
mutated region was ampliﬁed from genomic DNA by using Pfu
polymerase (Stratagene, La Jolla, CA), gel puriﬁed with a QIAquick
gel extraction kit (Qiagen, Inc., Valencia, CA), and sequenced (Elim
Biopharm, Inc., Hayward, CA). The preservation of the mutation
after replication in HELF was documented by DNA sequencing.
The replication kinetics of recombinant viruses were assessed
by an infectious focus assay with immunostaining to detect
plaques (Chaudhuri et al., 2008; Moffat et al., 1995). Brieﬂy, 6-
well assay plates and 24-well titer plates were seeded with MeWo
cells. Assay plates were incubated for variable times, and several
dilutions of the samples were taken for infectious focus assay. Titer
plates were incubated for 4 days then ﬁxed with 4% paraformal-
dehyde for immunohistochemical staining using anti-VZV mono-
clonal antibody (Meridian) and plaques were counted. Statistical
differences in growth kinetics based on plaque numbers were
determined by Student's t test.
Quantiﬁcation of VZV genome copies in melanoma cells
DNAwas extracted from VZV infected melanoma cells by phenol–
chloroform extraction followed by ethanol precipitation. Sso
Advanced PCR mix (Bio-Rad) was used to amplify partial regions
for the human β-actin gene using this set of primers, 50-TTTGA-
GACCTTCA ACACCCCAGCC-30 and 50-AATGTCACGCACGATTTCCCGC-
30, or VZV ORF31 using this set of primers, 50-ATGAAAACACTTTC-
TACCACG-30 and 50-AGAGTTTT GAAGTATAATGCG-30 using a C1000
thermal cycler with the CFX384 Real-Time system (Bio-Rad) con-
trolled by CFX Manager software version 1.6 (Bio-Rad) as described
by Oliver et al. (2013). The parameters for thermocycling were as
following: initial denaturation at 98 1C for 2 min followed by 39
cycles of denaturation at 98 1C for 5 s, annealing at 55 1C for 30 s, and
extension at 68 1C for 30 s. Melting-curve analysis was performed to
determine that single PCR products of the correct size were gener-
ated for all samples. For the quantiﬁcation of the human and VZV
DNA, two standards were used, β-actin gene was cloned into the
PCR4.0 vector (Life Technologies) and VZV ORF31 into the pcDNA
vector.
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